Additional material for this article is available from the James Lind Library website [www.jameslindlibrary.org] where this paper was previously published.
The introduction of inoculation for protection against smallpox in England in the early 1700s, and the gathering of quantitative data justifying its use, are a complex story. The best modern accounts of these developments are almost certainly those by two medical historians, Genevieve Miller 1 and Andrea Rusnock. 2 This commentary draws on their accounts, primary sources they cite, and other cited sources.
Smallpox, whether epidemic or endemic, was a prominent cause of death in 18th century England. Data from that period indicate deaths from smallpox averaged roughly 10% as a percentage of all deaths in affected regions, but sometimes up to approximately 20%. Greatly feared sequelae were severe disfigurement or blindness. Early in this century reports began to reach England through personal communications and formal documents that inoculating persons through skin incisions with material such as pustular matter from a patient with smallpox could prevent attacks of full-blown 'natural' smallpox. Especially influential reports were those of Emmanuel Timoni(us), an Italian physician, and Giacomo (Jacobus) Pylarinius, 3 a graduate of medicine at Padua, to the Royal Society of London. Timonius's report, a 1713 letter to the Royal Society of London, was called to the attention of members of the Society by John Woodward's summary of the letter. 4 'The Writer [Timonius] of this ingenious Discourse observes, in the first place, that the Circassians, Georgians, and other Asiaticks, have introduc'd this Practice of procuring the SmallPox by a sort of Inoculation, for about the space of forty Years, among the Turks and others at Constantinople.
That altho' at first the more prudent were very cautious in the use of this Practice; yet the happy Success it has been found to have in thousands of Subjects for these eight Years past, has now put it out of all suspicion and doubt; since the Operation having been perform'd on Persons of all Ages, Sexes, and different Temperaments, and even in the worst Constitution of the Air, yet none have been found to die of the Small-Pox; when at the same time it was very mortal when it seized the Patient the common way, of which half the affected dy'd. This he attests upon his own Observation.'
This practice was reported by others to be used in many other areas outside of western Europe, such as Greece, Armenia, and North Africa.
With such reports, the possibility of protecting persons against the risk of smallpox through inoculation became known among English physicians. But many were strongly reluctant to attempt this novel-for England-method of preventive treatment. It struck them as having a high risk of inducing a potentially fatal disease for which they had no clearly effective treatment. Some eminent members of the highest levels of London society were, or became, aware of the inoculations practiced in the Near East and sought inoculation in England for their children. Prominent among them was Lady Mary Wortley Montagu who became aware of inoculation when she was in Constantinople with her husband in his ambassadorial post. This excerpt from one of her letters represents her convictions.
'. . . I am going to tell you a thing that I am sure will make you wish yourself here. The small-pox, so fatal, and so general amongst us, is here entirely harmless by the invention of ingrafting, which is the term they give it. There is a set of old women who make it their business to perform the operation every autumn. . . . The old woman comes with a nut-shell full of the matter of the best sort of small-pox, and asks what veins you please to have opened. . . . She immediately rips open that you offer her with a large needle . . . and puts into the vein as much venom as can lie upon the head of her needle. . . . Every year thousands undergo this operation . . . There is no example of any one that has died in it; and you may believe I am well satisfied of the safety of the experiment. . . . I am patriot enough to take pains to bring this useful invention into fashion in England; and I should not fail to write to some of our doctors very particularly about it, if I knew any one of them that I
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M a y 2 0 0 6 Arrangements were made for a trial on six prisoners in Newgate, 6 three men matched for approximately the same ages with three women. All six survived and were pardoned. Indeed, Maitland arranged for a crude test of the efficacy of inoculation for the prevention of smallpox by having one of the women in the trial subsequently serve as a nurse to a young smallpox patient with whom she agreed to sleep. After 6 weeks of such exposure she had not fallen victim to smallpox. In time more physicians became aware of successful inoculations and began to offer it. Such favourable views in the profession of this novel procedure were not, however, universal, and the profession split into those violently opposed to the procedure and those supporting it.
Data gathered on mortality due to smallpox inoculation in the first half of the 18th century in England represent what was probably one of the first major attempts in any country to judge the validity of a medical treatment from quantitative data. This was not the first effort in England to consider healthcare issues with substantial quantitative data. It clearly stood in the tradition stemming from numerical analysis of the London Bills of Mortality initiated in the 17th century by two London tradesmen, John Graunt and Sir William Petty, who created the notion of 'political arithmetic'.
Directly relevant to the arguments on inoculation was Dr John Arbuthnot's tabulation of smallpox mortality in London for the years 1707-1718 in the Graunt and Petty tradition 2 (pp. 45-9). His anonymously published tabulation was cast as a vindication of the practice as represented by Charles Maitland, the inoculator of Lady Montagu's daughter. Arbuthnot calculated that the mortality rate in smallpox was 1 in 10 (10%) while estimating that from inoculation was only 1 in 100 (1%). He did not, however, publish data supporting his estimate of inoculation mortality.
Maitland was for a while the only inoculator, but other physicians and surgeons joined in. By 1722 at least 182 persons had been inoculated in England by physicians, surgeons, apothecaries, and a small number of inoculators of unidentified vocation. Among these was a physician in Halifax, Yorkshire, Dr. Thomas Nettleton. He had read the paper by John Woodward 4 in the Philosophical Transactions of the Royal Society of London on the report from Timonius and, probably, Pylarinius's account published in 1716. 3 Nettleton was also aware of the Newgate experiment. Facing an outbreak of smallpox in his region he decided to try this preventive measure. By 1722 Nettleton had inoculated at least 40 people in Halifax and neighboring towns. He initially reported his experiences in 'A Letter from Dr. Nettleton, Physician at Halifax in Yorkshire, to Dr. Whitaker, concerning the Inoculation of the Small Pox' published in the Philosophical Transactions of the Royal Society of London; 7 but he did not publish his initial data on the differences in mortality between inoculation cases and 'natural' cases until later in 1722. 8 'I would only . . . leave to remark, that it appears from these Accounts, that this last Year, in this Part of the Kingdom, almost nineteen out of every hundred, or near one fifth of those, who have had the natural Small Pox, have died; whereas out of sixty one which have been inoculated hereabouts, not one has died . . .' Preceding this passage is Nettleton's tabulation of cases of smallpox in his region in the preceding year and the number of resulting deaths-3405 cases with 636 deaths (a mortality rate of 18.8%)-these data being the basis for his 'near one fifth . . . who have had the natural Small Pox, have died'. The death rate in inoculated cases was 0%! Favourable views were held not only in England. In Boston, New England, an eminent non-physician, Cotton Mather, and a physician colleague, Dr Zabdiel Boylston, became strong supporters of inoculation. A terrible smallpox epidemic broke out in Boston in 1721 9 that stimulated Boylston to inoculate persons in an attempt to prevent their becoming infected. Mather had heard of inoculation from his African slave-servant and, through his being a corresponding Fellow of the Royal Society, had read of inoculation in the Philosophical Transactions. Hence Mather was supportive of Boylston in his efforts. Boylston travelled to London in 1725 and reported his data on inoculated persons to the Royal Society. His data became more widely known through his published account; 10 a table in it reports a low mortality among inoculated persons in the Boston region: of 247 persons inoculated by Boylston in 1721 and 1722, only six died (a mortality of 2.4%).
The strongest effort to judge the safety of inoculation was launched by the physician and mathematician, Dr James Jurin, Secretary of the Royal Society under Isaac Newton's presidency. Having become aware of Nettleton's data, he invested himself in developing a large correspondence On his page 13 he reviews the data of Jurin already published and some additional data available to him pertinent to the mortality rate in natural smallpox. Among 18 229 people 'Sick of the Small-Pox' 3008 died, 'one in six' (16.5%), 'which, considering the Largeness of the Numbers, we may lay down for the Hazard of the natural Small-Pox'.
Scheuchzer's table on page 24 summarizes the data, including those collected by Jurin, for people inoculated in the years 1721 through 1728. Those inoculated totalled 897. Of these, 845 were judged to have had smallpox from the inoculation, 13 had 'an imperfect Small-Pox', 39 'showed no effect', and 17 were 'supposed to have died'. If one assumes that the 39 represents people with either a technically inadequate inoculation or a prior immunity, the mortality rate from inoculation was 17 among 858 inoculees (a mortality rate of 2%). Hence the second question posed by Scheuchzer was answered affirmatively. The first, however, was not. Jurin and Scheuchzer did not have data from long-term follow ups on whether any inoculated people later developed 'natural' smallpox.
Jurin's and Scheuchzer's data did not end controversies over the propriety and efficacy of smallpox inoculation. Much of the opposition was based on religious grounds, but eventually inoculation became widely accepted. As Miller notes 1 (p. 168), 'In spite of sporadic opposition . . . there is no doubt that the smallpox pandemic of 1752 provided the final stimulus necessary to fix inoculation securely in the English medical armament'.
Inoculation was also practiced in the American colonies, but the only data on post-inoculation mortality reported after Boylston's appear to be those of Benjamin Franklin. 15 He had been asked by the eminent London physician, William Heberden, for data on the consequences of inoculation in the American colonies. His report was based on the inoculations stimulated by a Boston outbreak of smallpox in 1753 or 54. He reported for the Boston region that of 5059 'whites' who contracted smallpox 'in the common way', 452 died (a mortality rate of 8.9%). Of 485 'blacks' similarly infected, 62 died (a mortality rate of 12.8%). Of 1974 'whites' inoculated, 23 died (a mortality 264
M a y 2 0 0 6 rate of 1.2%); of 139 'blacks' inoculated, seven died (a mortality rate of 5.0%). He did not have exact numbers for Philadelphia but reports that of 'upwards of 800 [inoculated] . . . only four died (a maximum mortality rate of 0.5%). From today's perspective, the data gathered by Nettleton, Jurin, Scheuchzer, and others are imperfect proof of the efficacy of inoculation in preventing death from natural smallpox in that they did not know the exposure period or rate for inoculated persons. Given the high incidence of natural smallpox in England in the 18th century, efficacy does seem to have been reasonably well established. So the data gathered and analysed in the 1720s did represent numerical (quantitative) evidence for efficacy of a preventive treatment. But there was a growing awareness through the rest of the 18th century in England of the need for prospective trials adequately designed to yield fully convincing quantitative data for judgments on treatments. In this period, various views of this need have been described by Tröhler. 16 The efforts of Nettleton, Jurin, and Scheuchzer were a full century before Pierre Louis' advocacy of 'la méthode numerique' (numerical method) as he used it in studying the therapeutic value of bloodletting. Further, the procedure followed by Jurin Massey's point here relies on his assuming that those with natural smallpox may not have been 'treated with equal care'-care equaling that given to inoculated persons. He might have also pointed to possible nutritional differences between those with a 'natural case' of smallpox and inoculees. He may have been right on the 'equal care' issue, in that inoculation in the earliest years of the practice was given largely to the upper classes and mortality rates for 'natural cases' came from the wider population. The point he implies about the need for having all characteristics of cases in the two arms (naturally infected and inoculated) except for the 'treatment' (inoculation) and 'control cases (naturally infected) is sound, but he does not make it explicitly. Such control of homogeneity in comparisons of two or more arms of therapeutic assessments was attempted years later with case-control studies. However, the problem of heterogeneity of cases posed by Massey was eventually dealt with satisfactorily only in the second half of the 20th century, with the randomization of assignment to arms of a trial and subsequent statistical analysis of the effectiveness of randomization in distributing case differences efficiently in the two arms.
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